ReviewClinical pharmacokinetics2019

Clinical Pharmacokinetics of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer.

Takeshi Hirota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.